1 / 16

Pr JF Viallard Hôpital Haut-Lévêque, CHU BORDEAUX FRANCE

When to suspect a diagnosis of congenital inherited thrombocytopenia (CTP) ? Or when low platelet level does not mean immune thrombocytopenic purpura (ITP). Pr JF Viallard Hôpital Haut-Lévêque, CHU BORDEAUX FRANCE. Chronic thrombocytopenia in adult diagnostic procedure.

omer
Télécharger la présentation

Pr JF Viallard Hôpital Haut-Lévêque, CHU BORDEAUX FRANCE

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. When to suspect a diagnosis of congenital inherited thrombocytopenia (CTP)? Or when low platelet level does not mean immune thrombocytopenic purpura (ITP). Pr JF Viallard Hôpital Haut-Lévêque, CHU BORDEAUX FRANCE

  2. Chronic thrombocytopenia in adult diagnostic procedure • Pseudothrombocytopenia • Bone marrow examination • HIV, B- or C-hepatitis • Antinuclear antibodies, antiphospholipid antibodies,… • Coagulation tests • Schistocytes • hypogammaglobulinemia • Spleen echography

  3. ITP or CTP? • ITP: diagnosis of exclusion • A number of CTP had been misdiagnosed as ITP and the patients subjected to spleenectomy and/or cyclophosphamide, amongst other unappropriate therapies • Which patients must be explored?

  4. FOUR POINTS OF TRIAGE TO SUSPECT CONGENITAL THROMBOCYTOPENIA (CTP) • A family history of "ITP" • Absence of an increase in the platelet count in response to ITP treatments (refractory ITP) • Presence of certain "associated features" suggesting very specific diagnoses, for example thrombocytopenia with absent radii • Platelet size estimated on smear (blood smears are universally available)

  5. Reasons to suspect CTP: family history • Especially > 2 family members • Especially parent-child or maternal uncle-nephew • Non-specific criteria • Cases of familial ITP (autoimmune diseases)

  6. Reasons to suspect CTP: non-response to ITP treatment • Lack of platelet response to classical autoimmune thrombocytopenia therapies including IVIG, steroids, and spleenectomy • Non-specific criteria: refractory ITP • No exact definition of lack of response; no well-defined response thresholds • Arbitrarily: • > 30,000/µl increase from baseline: ITP • < 10,000/µl increase is compatible with CTP, but "refractory" ITP is possible.

  7. Reasons to suspect CTP: non-response to ITP treatment • Possible immunological component to the CTP • Impeding the clearance mechanism for aberrant platelets helps to offset impaired platelet production. • Since "spontaneous" fluctuation in the platelet count may occur (for example as a result of a viral infection), the assessment of two treatment responses is probably more helpful as a diagnostic criterion.

  8. Reasons to suspect CTP: associated features • In the patient or in a family member • Absence of radii (± other orthopaedic malformations) is suggestive of a TAR syndrome, • Severe thrombocytopenia in the first year of life with reduced megakaryocytes • Severe bleedings • their platelet counts increase with time • the platelets may fall again during adulthood • Signaling via the TPO receptor is abnormal

  9. Reasons to suspect CTP: associated features • Features of velocardiofacial (VCF) syndrome and DiGeorge syndrome : • T-cell defect (but variable clinical immunodeficiency) • Rightsided heart disease • Neonatal hypocalcemia • Cleft palate or bifid uvula • Neuro-psychologic issues • Acronym "CATCH22" (cardiac abnormality, T-cell deficit, cleft palate, hypocalcemia due to Chr22 deletion).

  10. Reasons to suspect CTP: associated features • Patients with either Wiskott-Aldrich syndrome (WAS) or the XLT form of WAS: • Marked or severe thrombocytopenia and smaller than normal platelets. • Severe infections (predilection to pneumococcal sepsis) • Eczema is common • Very young infants: milk allergy, and hematochezia • Frequent infections may overlap with immune thrombocytopenias secondary to hypogammaglobulinemia!

  11. Thrombocytopenia + large/giant platelets bleeding +/- Fechtner Syndrome (1985) : +leuko. Inclusions, nephritis, deafness, cataract Epstein Syndrome (1972): + nephritis, deafness Sebastian Syndrome (1990) : + leuko. inclusions May-Hegglin Anomaly : (1909; 1945) + leuko. inclusions Alport-like syndrome (1986): + nephritis, deafness, cataract Molecular basis : MYH9 mutations (Kelley 2000, Heath 2001, Seri 2002)

  12. Reasons to suspect CTP: review of the smear • Visual inspection of the smear remains the "gold standard" for platelet size in clinical practice • Large platelets: Bernard-Soulier syndrome or MYH9 defects. • Very small platelets: consistent with Wiskott-Aldrich • Platelet clumping may suggest von Willebrand type IIb

  13. Mutations MYH9 Döhle-like bodies (light-blue leukocytes inclusions) MHA FTNS FTNS MGG IC

  14. Other reasons to suspect hereditary thrombocytopenia • Bleeding out of proportion to the platelet count • Onset at birth • Persistence of a stable level of thrombocytopenia for years • Normal life span of platelets determined by isotopic platelet life span study despite low platelet level

  15. PERSPECTIVES • Certain patients do not fit into any of the known disorders • Refer to a specialist in inherited platelet disorders: • Number and morphology of megakaryocytes • MK colonies assays • MK cultures • Platelet function and aggregation studies with high platelet concentrations • Plasma TPO, glycocalicin levels • New therapies: TPO

  16. ACKNOWLEDGEMENTS • A Nurden and P Nurden, Centre de Référence des pathologies plaquettaires rares, Hôpital Haut-Lévêque, BORDEAUX

More Related